US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5681811A
(en)
*
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
US5359030A
(en)
*
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
KR100361933B1
(ko)
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
DE4437502A1
(de)
*
|
1993-12-02 |
1995-06-08 |
Basf Ag |
Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen
|
US5567592A
(en)
*
|
1994-02-02 |
1996-10-22 |
Regents Of The University Of California |
Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
|
RU2066551C1
(ru)
*
|
1994-03-23 |
1996-09-20 |
Институт нефтехимического синтеза РАН |
Способ получения инсулинсодержащих полимерных гидрогелей
|
DE69533987T2
(de)
*
|
1994-05-20 |
2006-03-16 |
Hisamitsu Pharmaceutical Co., Inc., Tosu |
Protein oder polypeptid, verfahren zur seiner herstellung und entsprechende zwischenprodukte
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US5869602A
(en)
*
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
US6004583A
(en)
*
|
1995-03-22 |
1999-12-21 |
Orex Pharmaceutical Development Corp. |
Protein-containing polymer composition for oral administration
|
CA2279673A1
(en)
*
|
1995-12-15 |
1997-06-16 |
Enzo Therapeutics, Inc. |
Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses
|
TW517067B
(en)
*
|
1996-05-31 |
2003-01-11 |
Hoffmann La Roche |
Interferon conjugates
|
BR9710908A
(pt)
*
|
1996-08-02 |
2000-10-24 |
Orex Pharmaceutical Dev Corp |
Composição de polìmero contendo proteìna para administração oral
|
US6503881B2
(en)
*
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
US6180604B1
(en)
|
1996-08-21 |
2001-01-30 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using analogues of indolicidin
|
US6072040A
(en)
*
|
1996-10-15 |
2000-06-06 |
Medical Analysis Systems, Inc. |
Stabilized conjugates of uncomplexed subunits of multimeric proteins
|
US6132712A
(en)
*
|
1996-12-11 |
2000-10-17 |
A. Glenn Braswell |
Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same
|
US5993856A
(en)
*
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
US6416778B1
(en)
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
US5804183A
(en)
*
|
1997-01-31 |
1998-09-08 |
Enzon, Inc. |
Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
|
CA2288994C
(en)
*
|
1997-04-30 |
2011-07-05 |
Enzon, Inc. |
Polyalkylene oxide-modified single chain polypeptides
|
US20040009166A1
(en)
*
|
1997-04-30 |
2004-01-15 |
Filpula David R. |
Single chain antigen-binding polypeptides for polymer conjugation
|
ATE469166T1
(de)
*
|
1997-06-06 |
2010-06-15 |
Kyowa Hakko Kirin Co Ltd |
Chemisch modifizierte polypeptide
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US6165458A
(en)
*
|
1997-12-26 |
2000-12-26 |
Pharmaderm Laboratories Ltd. |
Composition and method for dermal and transdermal administration of a cytokine
|
JP2002506792A
(ja)
*
|
1998-02-27 |
2002-03-05 |
ノボ ノルディスク アクティーゼルスカブ |
N末端修飾glp−1誘導体
|
AU3247799A
(en)
*
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
KR19990085365A
(ko)
*
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
DK1087778T3
(da)
*
|
1998-06-08 |
2005-12-19 |
Hoffmann La Roche |
Anvendelse af PEG-IFN-alfa og Ribavirin til behandling af kronisk hepatitis C
|
US6703381B1
(en)
*
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
CN1329082C
(zh)
*
|
1998-10-16 |
2007-08-01 |
拜奥根Idec马萨诸塞公司 |
干扰素-β-1a的聚合物缀合物及其使用
|
TR200101087T2
(tr)
*
|
1998-10-16 |
2001-09-21 |
Biogen, Inc. |
İnterferon beta-füzyon proteinleri ve kullanımları
|
US6333396B1
(en)
|
1998-10-20 |
2001-12-25 |
Enzon, Inc. |
Method for targeted delivery of nucleic acids
|
US6458953B1
(en)
*
|
1998-12-09 |
2002-10-01 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising carbamate linkages
|
EP1183230A1
(de)
*
|
1999-06-08 |
2002-03-06 |
La Jolla Pharmaceutical |
Valenz-plattformmoleküle mit aminooxygruppen
|
US6209490B1
(en)
*
|
1999-06-17 |
2001-04-03 |
Gary J. Schwede |
Living quarters container for cats or ferrets
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US6309633B1
(en)
*
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
JO2291B1
(en)
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
KR100345214B1
(ko)
*
|
1999-08-17 |
2002-07-25 |
이강춘 |
생체적합성 고분자가 수식된 펩타이드의 비점막 전달
|
US6323311B1
(en)
|
1999-09-22 |
2001-11-27 |
University Of Utah Research Foundation |
Synthesis of insulin derivatives
|
DE60032255T2
(de)
*
|
1999-10-04 |
2007-06-28 |
Nektar Therapeutics Al, Corp., Huntsville |
Polymer-stabilisierte neuropeptide
|
RU2155602C1
(ru)
|
1999-11-30 |
2000-09-10 |
Оао "Куантум Сатис" |
Инсулинсодержащее лекарственное средство для перорального применения и способ его получения
|
US6638906B1
(en)
*
|
1999-12-13 |
2003-10-28 |
Nobex Corporation |
Amphiphilic polymers and polypeptide conjugates comprising same
|
EP1270642B1
(de)
*
|
1999-12-24 |
2011-08-31 |
Kyowa Hakko Kirin Co., Ltd. |
Verzweigte polyalkylenglykole
|
AU4267700A
(en)
*
|
2000-01-13 |
2001-07-19 |
Academia Sinica |
Application of somatostatin analogs to specific delivery of anti-tumor drugs into tumor cells
|
KR100890125B1
(ko)
|
2000-02-24 |
2009-03-24 |
일라이 릴리 앤드 캄파니 |
소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
|
JP2003535208A
(ja)
|
2000-06-08 |
2003-11-25 |
ラ ホヤ ファーマシューティカル カンパニー |
高分子量ポリエチレン・オキシドを含む多価プラットホーム分子
|
MXPA03000073A
(es)
|
2000-06-26 |
2003-09-25 |
Monsanto Technology Llc |
Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina.
|
US6664234B1
(en)
|
2000-06-30 |
2003-12-16 |
Monsanto Technology Llc |
Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
|
US7105154B2
(en)
*
|
2000-07-19 |
2006-09-12 |
Pepgen Corporation |
Method of treatment using interferon-tau
|
SK2772003A3
(en)
*
|
2000-09-08 |
2003-10-07 |
Gryphon Therapeutics Inc |
Synthetic erythropoiesis stimulating proteins
|
US20030054015A1
(en)
*
|
2000-12-25 |
2003-03-20 |
Shinichiro Haze |
Sympathetic-activating perfume composition
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6538104B2
(en)
|
2001-04-27 |
2003-03-25 |
Medical Analysis Systems, Inc. |
Stabilization of cardiac troponin I subunits and complexes
|
US20030108585A1
(en)
*
|
2001-05-04 |
2003-06-12 |
Roe R. Michael |
Polymer conjugates of insecticidal peptides or nucleic acids or insecticides and methods of use thereof
|
WO2002089830A1
(en)
*
|
2001-05-04 |
2002-11-14 |
North Carolina State University |
Polymer conjugates of insecticidal peptides or nucleic acids and methods of use thereof
|
EA007408B1
(ru)
|
2001-05-21 |
2006-10-27 |
Нектар Терапьютикс |
Легочное введение химически модифицированного инсулина
|
EP1405871A4
(de)
*
|
2001-05-30 |
2004-11-17 |
Mitsubishi Kagaku Iatron Inc |
Verfahren zum binden einer an einem polymerende zu inkorporierenden substanz
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7008650B2
(en)
*
|
2001-08-09 |
2006-03-07 |
Lam Paul Y S |
Compositions for the treatment of acquired immunodeficiency disease
|
US6835536B2
(en)
|
2001-08-21 |
2004-12-28 |
Micrologix Biotech Inc. |
Antimicrobial cationic peptides and formulations thereof
|
JP4511173B2
(ja)
|
2001-08-24 |
2010-07-28 |
マイジェニックス インコーポレイテッド |
抗菌性および抗炎症性ペプチド
|
ATE446971T1
(de)
*
|
2001-09-07 |
2009-11-15 |
Biocon Ltd |
Verfahren zur synthese von insulinpolypeptid- oligomer-konjugaten und proinsulinpolypeptid- oligomer-konjugaten und verfahren zu deren synthese
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7166571B2
(en)
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
AU2002352524B2
(en)
*
|
2001-11-07 |
2007-10-04 |
Nektar Therapeutics |
Branched polymers and their conjugates
|
US20030171285A1
(en)
*
|
2001-11-20 |
2003-09-11 |
Finn Rory F. |
Chemically-modified human growth hormone conjugates
|
CA2471400A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Femmepharma, Inc. |
Vaginal delivery of drugs
|
JP2006501137A
(ja)
*
|
2002-01-16 |
2006-01-12 |
ペプジェン コーポレイション |
インターフェロン−τの経口投与
|
KR100964411B1
(ko)
|
2002-01-18 |
2010-06-15 |
바이오겐 아이덱 엠에이 인코포레이티드 |
생물학적 활성 화합물과 컨쥬게이팅되는 잔기를 갖는 폴리알킬렌 글리콜
|
JP2006518701A
(ja)
*
|
2002-05-24 |
2006-08-17 |
ネオファーム、インコーポレイティッド |
カルジオリピン組成物、その製造方法及び使用
|
EA200401565A1
(ru)
*
|
2002-05-24 |
2005-04-28 |
Неофарм, Инк. |
Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
|
US7601688B2
(en)
*
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
US7459435B2
(en)
*
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
WO2004021993A2
(en)
*
|
2002-09-05 |
2004-03-18 |
The General Hospital Corporation |
Modified asialo-interferons and uses thereof
|
US20050277611A1
(en)
*
|
2002-10-16 |
2005-12-15 |
Neopharm, Inc. |
Cationic cardiolipin analoges and its use thereof
|
AU2003285200A1
(en)
*
|
2002-11-09 |
2004-06-03 |
Nobex Corporation |
Modified carbamate-containing prodrugs and methods of synthesizing same
|
US7459436B2
(en)
*
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US7648962B2
(en)
*
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
DE60331584D1
(de)
*
|
2002-11-26 |
2010-04-15 |
Biocon Ltd |
Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen
|
MXPA05006994A
(es)
*
|
2002-12-27 |
2005-10-18 |
Diobex Inc |
Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina.
|
US7655618B2
(en)
*
|
2002-12-27 |
2010-02-02 |
Diobex, Inc. |
Compositions and methods for the prevention and control of insulin-induced hypoglycemia
|
MXPA05007266A
(es)
*
|
2003-01-02 |
2006-01-17 |
Femmepharma Holding Co Inc |
Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
US7074755B2
(en)
*
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
JP2007537986A
(ja)
*
|
2003-05-30 |
2007-12-27 |
セントカー・インコーポレーテツド |
トランスグルタミナーゼを用いる新規なエリトロポエチン複合体の形成
|
US20060078560A1
(en)
*
|
2003-06-23 |
2006-04-13 |
Neopharm, Inc. |
Method of inducing apoptosis and inhibiting cardiolipin synthesis
|
BRPI0412265A
(pt)
|
2003-07-23 |
2006-09-05 |
Novartis Ag |
uso de calcitonina em osteoartrite
|
JP4880461B2
(ja)
|
2003-08-13 |
2012-02-22 |
バイオコン・リミテッド |
治療薬用のマイクロ粒子脂肪酸塩固体製剤
|
DK1696947T3
(en)
*
|
2003-12-19 |
2014-03-17 |
Hoffmann La Roche |
APPLICATION OF ERYTHROPOIETIN IN THE TREATMENT OF DISORDERS OF THE IRON DISTRIBUTION IN CHRONIC INFLAMMATORY INTESTINAL DISEASES
|
WO2005063156A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Shear/Kershman Laboratories, Inc. |
Oral peptide delivery system with improved bioavailability
|
SE0401942D0
(sv)
*
|
2004-07-28 |
2004-07-28 |
Lipopeptide Ab |
New antimicrobial peptide complexes
|
JP2008505853A
(ja)
|
2004-04-13 |
2008-02-28 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
細胞傷害性薬剤としての非天然のリボヌクレアーゼ複合体
|
US8329958B2
(en)
|
2004-07-02 |
2012-12-11 |
Biocon Limited |
Combinatorial synthesis of PEG oligomer libraries
|
EP1773878B1
(de)
*
|
2004-07-19 |
2015-03-04 |
Biocon Limited |
Insulinoligomerkonjugate, formulierungen und anwendungen davon
|
AU2005271526B2
(en)
*
|
2004-08-03 |
2011-12-08 |
Emisphere Technologies, Inc. |
Antidiabetic oral insulin-biguanide combination
|
TW200612993A
(en)
*
|
2004-10-08 |
2006-05-01 |
Alza Corp |
Lipopolymer conjugates
|
US20080207505A1
(en)
*
|
2005-01-12 |
2008-08-28 |
James Kenneth D |
Bna Conjugates and Methods of Use
|
JP2008528549A
(ja)
*
|
2005-01-27 |
2008-07-31 |
ノボ ノルディスク アクティーゼルスカブ |
構造的に充分に定義された分岐ポリマーと接合されたインスリン誘導体
|
WO2006082205A1
(en)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Insulin derivatives
|
WO2007007345A1
(en)
*
|
2005-07-08 |
2007-01-18 |
Biocon Limited |
Preparation of insulin conjugates
|
US8568705B2
(en)
|
2005-07-18 |
2013-10-29 |
Nektar Therapeutics |
Method for preparing branched functionalized polymers using branched polyol cores
|
ES2546016T3
(es)
*
|
2005-10-13 |
2015-09-17 |
Biocon Limited |
Procedimiento para la preparación de conjugados de insulina
|
CN101534846B
(zh)
*
|
2005-11-07 |
2014-11-05 |
印第安纳大学研究及科技有限公司 |
显示生理学溶解性和稳定性的胰高血糖素类似物
|
EP1951207A2
(de)
|
2005-11-17 |
2008-08-06 |
Novartis AG |
Pharmazeutische zusammensetzung
|
GB0604187D0
(en)
*
|
2006-03-02 |
2006-04-12 |
Fusion Antibodies Ltd |
Peptide and uses thereof
|
WO2007115175A2
(en)
|
2006-03-30 |
2007-10-11 |
Palatin Technologies, Inc. |
Cyclic natriuretic peptide constructs
|
US8580746B2
(en)
*
|
2006-03-30 |
2013-11-12 |
Palatin Technologies, Inc. |
Amide linkage cyclic natriuretic peptide constructs
|
AU2007233123A1
(en)
*
|
2006-03-30 |
2007-10-11 |
Palatin Technologies, Inc. |
Linear natriuretic peptide constructs
|
JP5269767B2
(ja)
*
|
2006-05-09 |
2013-08-21 |
ノボ・ノルデイスク・エー/エス |
インスリン誘導体
|
US20100029554A1
(en)
|
2006-05-26 |
2010-02-04 |
Amylin Pharmaceuticals, Inc. |
Composition and Methods for Treatment of Congestive Heart Failure
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
WO2007149594A2
(en)
*
|
2006-06-23 |
2007-12-27 |
Quintessence Biosciences, Inc. |
Modified ribonucleases
|
EP2049151A4
(de)
|
2006-07-17 |
2010-03-24 |
Quintessence Biosciences Inc |
Verfahren und zusammensetzungen zur behandlung von krebs
|
EP2049149B1
(de)
|
2006-07-31 |
2015-04-15 |
Novo Nordisk A/S |
Pegylierte verlängerte insuline
|
US8501693B2
(en)
*
|
2006-08-04 |
2013-08-06 |
Amylin Pharmaceuticals, Llc |
Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
|
PL2074141T3
(pl)
*
|
2006-09-22 |
2017-02-28 |
Novo Nordisk A/S |
Analogi insuliny oporne na proteazę
|
EP2081587A2
(de)
*
|
2006-10-18 |
2009-07-29 |
Research Development Foundation |
Alpha-msh-therapien zur behandlung von autoimmun-krankheiten
|
EP2104489A2
(de)
*
|
2006-12-26 |
2009-09-30 |
FemmePharma Holding Company, Inc. |
Topische verabreichung von danazol
|
EP2124974B1
(de)
*
|
2007-01-05 |
2017-03-15 |
Indiana University Research and Technology Corporation |
Glocagonanaloga mit erhöhter löslichkeit in physiologischen ph-puffern
|
AU2008216265B2
(en)
|
2007-02-15 |
2014-04-03 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
EP2152245B1
(de)
*
|
2007-04-30 |
2015-12-02 |
Novo Nordisk A/S |
Verfahren zum Trocknen einer Proteinzusammensetzung, getrocknete Proteinzusammensetzung und pharmazeutische Zusammensetzungen mit dem getrockneten Protein
|
EP2497462A1
(de)
*
|
2007-06-01 |
2012-09-12 |
Novo Nordisk A/S |
Stabile nichtwässrige pharmazeutische Zusammensetzungen
|
US7776827B2
(en)
*
|
2007-07-27 |
2010-08-17 |
Immuneregen Biosciences, Inc. |
Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome
|
WO2009048909A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Quintessence Biosciences, Inc. |
Compositions and methods for ribonuclease-based therapies
|
WO2009050738A2
(en)
|
2007-10-16 |
2009-04-23 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
CA2707861A1
(en)
|
2007-10-30 |
2009-05-07 |
Indiana University Research And Technology Corporation |
Glucagon antagonists
|
ES2558155T3
(es)
*
|
2007-10-30 |
2016-02-02 |
Indiana University Research And Technology Corporation |
Compuestos que muestran actividad antagonista de glucacón y agonista de GLP-1
|
JP2011511778A
(ja)
|
2008-01-30 |
2011-04-14 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション |
エステルに基づいたペプチドプロドラッグ
|
US9260502B2
(en)
*
|
2008-03-14 |
2016-02-16 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
US8691759B2
(en)
|
2008-03-18 |
2014-04-08 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
US20090271021A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Popp Shane M |
Execution system for the monitoring and execution of insulin manufacture
|
TWI541023B
(zh)
*
|
2008-06-17 |
2016-07-11 |
印第安納大學科技研究公司 |
在生理ph緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
|
EA020326B9
(ru)
*
|
2008-06-17 |
2015-03-31 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Агонисты смешанного действия на основе глюкозозависимого инсулинотропного пептида для лечения нарушений обмена веществ и ожирения
|
CL2009001424A1
(es)
|
2008-06-17 |
2010-04-30 |
Univ Indiana Res & Tech Corp |
Peptido tipo glucagon; dimero que comprende dos de dichos peptidos; composicion farmaceutica que lo comprende; y su uso para tratar diabetes o inducir perdida de peso.
|
MX2011000847A
(es)
*
|
2008-08-06 |
2011-02-25 |
Novo Nordisk Healthcare Ag |
Proteinas conjugadas con eficacia prolongada in vivo.
|
EP2898900B1
(de)
|
2008-09-19 |
2017-11-15 |
Nektar Therapeutics |
Polymerkonjugate von Ziconotid
|
US20110171312A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Modified therapeutic peptides, methods of their preparation and use
|
CN102227443B
(zh)
|
2008-10-01 |
2014-05-14 |
昆特森斯生物科学公司 |
治疗性核糖核酸酶
|
JP5755566B2
(ja)
|
2008-12-19 |
2015-07-29 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
アミド系インスリンプロドラッグ
|
JP5789515B2
(ja)
|
2008-12-19 |
2015-10-07 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
インスリン類似体
|
CA2747499A1
(en)
|
2008-12-19 |
2010-06-24 |
Indiana University Research And Technology Corporation |
Amide based glucagon superfamily peptide prodrugs
|
US8513192B2
(en)
|
2009-01-22 |
2013-08-20 |
Novo Nordisk A/S |
Stable growth hormone compounds resistant to proteolytic degradation
|
US9238878B2
(en)
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
KR101673042B1
(ko)
|
2009-03-12 |
2016-11-04 |
키바이오사이언스 아게 |
당뇨병 및 대사 증후군의 치료
|
MX2011013625A
(es)
|
2009-06-16 |
2012-01-20 |
Univ Indiana Res & Tech Corp |
Compuestos glucagon activo de receptor de gip.
|
US20110003000A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Femmepharma Holding Company, Inc. |
Transvaginal Delivery of Drugs
|
WO2011003633A1
(en)
|
2009-07-06 |
2011-01-13 |
Alize Pharma Ii |
Pegylated l-asparaginase
|
HUP0900482A2
(en)
|
2009-08-03 |
2011-03-28 |
Cera Med Kft |
Pharmaceutical formulation for oral administration
|
JP6086528B2
(ja)
|
2009-08-06 |
2017-03-01 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
長期のインビボ有効性を有する成長ホルモン
|
EP2488195A2
(de)
*
|
2009-10-13 |
2012-08-22 |
F. Hoffmann-La Roche AG |
Neuropeptid-2-rezeptor (y-2r)-agonisten
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
SG181769A1
(en)
|
2009-12-21 |
2012-07-30 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
CA2784793A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
RU2012134974A
(ru)
|
2010-01-22 |
2014-02-27 |
Ново Нордиск Хелс Кеа Аг |
Стабилизированное соединение гормона роста
|
TWI508737B
(zh)
|
2010-01-22 |
2015-11-21 |
諾佛 儂迪克股份有限公司 |
具有延長的活體內功效的生長激素
|
RU2012136450A
(ru)
|
2010-01-27 |
2014-03-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Конъюгаты антагонист глюкагона - агонист gip и композиции для лечения метаболических расстройств и ожирения
|
US9127088B2
(en)
|
2010-05-13 |
2015-09-08 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
|
JP6050746B2
(ja)
|
2010-05-13 |
2016-12-21 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
Gタンパク質共役受容体活性を示すグルカゴンスーパーファミリーのペプチド
|
US8940860B2
(en)
|
2010-06-16 |
2015-01-27 |
Indiana University Research And Technology Corporation |
Single-chain insulin agonists exhibiting high activity at the insulin receptor
|
RU2580317C2
(ru)
|
2010-06-24 |
2016-04-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Пептидные пролекарства, принадлежащие к суперсемейству амид-содержащих глюкагонов
|
JP5912112B2
(ja)
|
2010-06-24 |
2016-04-27 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
アミド系インスリンプロドラッグ
|
SG191194A1
(en)
|
2010-12-22 |
2013-07-31 |
Univ Indiana Res & Tech Corp |
Glucagon analogs exhibiting gip receptor activity
|
CN103415621A
(zh)
|
2011-01-14 |
2013-11-27 |
雷德伍德生物科技股份有限公司 |
醛标记免疫球蛋白多肽及其使用方法
|
CN103748109A
(zh)
|
2011-06-22 |
2014-04-23 |
印第安纳大学研究及科技有限公司 |
胰高血糖素/glp-1受体共同激动剂
|
JP6179864B2
(ja)
|
2011-06-22 |
2017-08-16 |
インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション |
グルカゴン/glp−1レセプタコ−アゴニスト
|
AU2012301793A1
(en)
*
|
2011-08-30 |
2014-03-20 |
Quanta Biodesign, Ltd. |
Branched discrette PEG constructs
|
ES2673617T3
(es)
|
2011-11-02 |
2018-06-25 |
Keybioscience Ag |
Miméticos de calcitonina para tratar enfermedades y trastornos
|
CN103998052B
(zh)
|
2011-11-02 |
2016-08-17 |
关键生物科学有限公司 |
用于治疗疾病和紊乱的肽类似物
|
BR112014007124A2
(pt)
|
2011-11-17 |
2017-06-13 |
Univ Indiana Res & Tech Corp |
superfamília de peptídeos gluxagon que exibem atividade no receptor glicocorticóide
|
JP6392123B2
(ja)
|
2011-12-20 |
2018-09-19 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
糖尿病治療のためのctp系インスリンアナローグ
|
JP6375289B2
(ja)
*
|
2012-04-05 |
2018-08-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
免疫刺激組成物およびその使用方法
|
BR112014025132A2
(pt)
|
2012-04-11 |
2017-07-11 |
Novo Nordisk As |
formulações de insulina
|
MX2014015558A
(es)
|
2012-06-21 |
2015-03-05 |
Univ Indiana Res & Tech Corp |
Analogos de glucagon que exhiben actividad del receptor gip.
|
CA2886228A1
(en)
|
2012-09-26 |
2014-04-03 |
Indiana University Research And Technology Corporation |
Insulin analog dimers
|
BR112015023071A2
(pt)
|
2013-03-14 |
2017-07-18 |
Univ Indiana Res & Tech Corp |
conjugados de insulina-incretina
|
ES2841123T3
(es)
|
2013-04-05 |
2021-07-07 |
Formulacion Del Compuesto De La Hormona De Crecimiento |
Formulación del compuesto de la hormona de crecimiento
|
CN105813652A
(zh)
*
|
2013-04-30 |
2016-07-27 |
麻省理工学院 |
用于糖尿病治疗的可注射纳米网络凝胶
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
DK3055325T3
(en)
|
2013-10-07 |
2018-04-16 |
Novo Nordisk As |
New derivative of an insulin analogue
|
SI3321278T1
(sl)
|
2013-11-14 |
2019-04-30 |
Keybioscience Ag |
Mimetiki kalcitonina za zdravljenje bolezni in motenj
|
US10385107B2
(en)
|
2014-09-24 |
2019-08-20 |
Indiana Univeresity Researc and Technology Corporation |
Lipidated amide-based insulin prodrugs
|
US10232020B2
(en)
|
2014-09-24 |
2019-03-19 |
Indiana University Research And Technology Corporation |
Incretin-insulin conjugates
|
CA2967649A1
(en)
*
|
2014-11-21 |
2016-05-26 |
The University Of Chicago |
Synthetic peptides
|
US10046058B2
(en)
|
2014-12-02 |
2018-08-14 |
Rezolute, Inc. |
Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates
|
GB201500263D0
(en)
|
2015-01-08 |
2015-02-25 |
Keybioscience Ag |
Calcitonin analogues for treating diseases and disorders
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9744239B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
RU2730848C2
(ru)
|
2015-06-04 |
2020-08-26 |
Резолют, Инк. |
Способы пэгилирования по аминогруппе для получения сайт-специфичных конъюгатов белков
|
CN109071634A
(zh)
|
2016-04-26 |
2018-12-21 |
R.P.谢勒技术有限责任公司 |
抗体偶联物及其制备和使用方法
|
CN110087674B
(zh)
|
2016-12-16 |
2023-01-03 |
诺和诺德股份有限公司 |
含胰岛素的药物组合物
|
WO2018136779A2
(en)
|
2017-01-19 |
2018-07-26 |
The University Of Chicago |
OXALOBACTER FORMIGENES(Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS
|
GB201704429D0
(en)
|
2017-03-21 |
2017-05-03 |
Keybioscience Ag |
Calcitonin mimetics for treating diseases and disorders
|
GB201707955D0
(en)
|
2017-05-18 |
2017-07-05 |
Keybioscience Ag |
Dual amylin and calcitonin receptor agonists for treating diseases and disorders
|
US10174302B1
(en)
|
2017-06-21 |
2019-01-08 |
Xl-Protein Gmbh |
Modified L-asparaginase
|
GB201813678D0
(en)
|
2018-08-22 |
2018-10-03 |
Keybioscience Ag |
Acylated calcitonin mimetics
|
GB201813677D0
(en)
|
2018-08-22 |
2018-10-03 |
Keybioscience Ag |
Calcitonin mimetics for treating diseases and disorders
|